• OPEN AN ACCOUNT
Indian Indices
Sensex
78,154.25 -388.19
( -0.49%)
Global Indices
Nasdaq
53,805.64 -191.34
(-0.35%)
Dow Jones
7,747.95 -26.16
(-0.34%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,849.18 -13.32
(-0.12%)
Forex
USD-INR
95.15 -0.05
(-0.05%)
EUR-INR
109.97 0.14
(0.13%)
GBP-INR
128.34 0.21
(0.16%)
JPY-INR
0.60 0.00
(0.09%)

EQUITY - MARKET SCREENER

Ramky Infrastructure Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
533262
INE874I01013
260.1467135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RAMKY
13.56
2733.66
EPS(TTM)
Face Value()
Div & Yield %
29.14
10
0.25
 

Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
May 29,2026
Net profit of Fredun Pharmaceuticals rose 79.67% to Rs 10.78 crore in the quarter ended March 2026 as against Rs 6.00 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 65.25% to Rs 32.62 crore in the year ended March 2026 as against Rs 19.74 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.7310.43 -13.9212.16 -
PBDT14.409.10 58 55.2432.53 70
PBT11.257.26 55 47.0027.49 71
NP10.786.00 80 32.6219.74 65